Gleason grading systemProstate cancer - Gleason; Adenocarcinoma prostate - Gleason; Gleason score; Prostate cancer - 5 grade group
Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-shaped structure that makes up part of a man's reproduc...Read Article Now Book Mark Article
A biopsy is the removal of a small piece of tissue for laboratory examination.Read Article Now Book Mark Article
The Gleason grading system refers to how abnormal your prostate cancer cells look and how likely the cancer is to advance and spread. A lower Gleason grade means that the cancer is slower growing and not aggressive.
The first step in determining the Gleason grade is to determine the Gleason score.
- When looking at cells under the microscope, the doctor assigns a number (or grade) to the prostate cancer cells between 1 and 5.
- This grade is based on how abnormal the cells appear. Grade 1 means that the cells look almost like normal prostate cells. Grade 5 means that the cells look very different from normal prostate cells.
- Most prostate cancers contain cells that are different grades. So the two most common grades are used.
- The Gleason score is determined by adding the two most common grades. For example, the most common grade of the cells in a tissue sample may be grade 3 cells, followed by grade 4 cells. The Gleason score for this sample would be 7.
Higher numbers indicate a faster growing cancer that is more likely to spread.
Currently the lowest score assigned to a tumor is grade 6. Scores below a 6 show normal to near normal cells. Most cancers have a Gleason score of between 5 and 7.
Gleason Grading System
Sometimes, it can be hard to predict how well people will do based just on their Gleason scores alone.
- For example, your tumor may be assigned a Gleason score of 7 if the two most common grades were 3 and 4.The 7 may come either from adding 3 + 4 or from adding 4 + 3.
- Overall, someone with a Gleason score of 7 that comes from adding 3 + 4 is felt to have a less aggressive cancer than someone with a Gleason score of 7 that comes from adding 4 + 3. That is because the person with a 4 + 3 =7 grade has more grade 4 cells than grade 3 cells. Grade 4 cells are more abnormal and more likely to spread than grade 3 cells.
A new 5 Grade Group System has recently been created. This system is a better way to describe how a cancer will behave and respond to treatment.
- Grade group 1: Gleason score 6 or lower (low-grade cancer)
- Grade group 2: Gleason score 3 + 4 = 7 (medium-grade cancer)
- Grade group 3: Gleason score 4 + 3 = 7 (medium-grade cancer)
- Grade group 4: Gleason score 8 (high-grade cancer)
- Grade group 5: Gleason score 9 to 10 (high-grade cancer)
A lower group indicates a better chance for successful treatment than a higher group. A higher group means that more of the cancer cells look different from normal cells. A higher group also means that it is more likely that the tumor will spread aggressively.
Grading helps you and your doctor determine your treatment options, along with:
- Stage of the cancer, which shows how much the cancer has spread
- PSA test result
- Your overall health
- Your desire to have surgery, radiation, or hormone medicines, or no treatment at all
Epstein JI. Pathology of prostatic neoplasia. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 11th ed. Philadelphia, PA: Elsevier; 2016:chap 110.
Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016;69(3):428-435. PMID: 26166626 www.ncbi.nlm.nih.gov/pubmed/26166626.
Gordetsky J, Epstein J. Grading of prostatic adenocarcinoma: current state and prognostic implications. Diagn Pathol. 2016;11:25. PMID: 26956509 www.ncbi.nlm.nih.gov/pubmed/26956509.
Review Date: 5/31/2018
Reviewed By: Sovrin M. Shah, MD, Assistant Professor, Department of Urology, The Icahn School of Medicine at Mount Sinai, New York, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.